These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


103 related items for PubMed ID: 11952049

  • 1. Radiotherapy for Graves' ophthalmopathy: results at one year.
    Gorman CA.
    Thyroid; 2002 Mar; 12(3):251-5. PubMed ID: 11952049
    [Abstract] [Full Text] [Related]

  • 2. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy.
    Gorman CA, Garrity JA, Fatourechi V, Bahn RS, Petersen IA, Stafford SL, Earle JD, Forbes GS, Kline RW, Bergstralh EJ, Offord KP, Rademacher DM, Stanley NM, Bartley GB.
    Ophthalmology; 2001 Sep; 108(9):1523-34. PubMed ID: 11535445
    [Abstract] [Full Text] [Related]

  • 3. A Prospective, Randomized, Double-blind, Placebo-controlled Study of Orbital Radiotherapy for Graves' Ophthalmopathy.
    Gorman CA, Garrity JA, Fatourechi V, Bahn RS, Petersen IA, Stafford SL, Earle JD, Forbes GS, Kline RW, Bergstralh EJ, Offord KP, Rademacher DM, Stanley NM, Bartley GB.
    Ophthalmology; 2020 Apr; 127(4S):S160-S171. PubMed ID: 32200817
    [Abstract] [Full Text] [Related]

  • 4. [Effects of external orbital radiotherapy on the oculomotor muscle in Graves disease].
    Maalouf T, Angioi-Duprez K, Beckendorff V, Malet T, George JL.
    J Fr Ophtalmol; 1996 Apr; 19(12):748-54. PubMed ID: 9033899
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Therapy of Graves' ophthalmopathy with intravenous high-dose steroid followed by orbital irradiation.
    Koshiyama H, Koh T, Fujiwara K, Hayakawa K, Shimbo S, Misaki T.
    Thyroid; 1994 Apr; 4(4):409-13. PubMed ID: 7711503
    [Abstract] [Full Text] [Related]

  • 13. Treatment of Graves' ophthalmopathy by steroid therapy, orbital radiation therapy, plasmapheresis and thyroxine replacement.
    Yamamoto K, Saito K, Takai T, Yoshida S.
    Endocrinol Jpn; 1982 Aug; 29(4):495-501. PubMed ID: 6897533
    [Abstract] [Full Text] [Related]

  • 14. The measurement of change in Graves' ophthalmopathy.
    Gorman CA.
    Thyroid; 1998 Jun; 8(6):539-43. PubMed ID: 9669294
    [Abstract] [Full Text] [Related]

  • 15. Clinical experience of radiation therapy for Graves' ophthalmopathy.
    Takahashi T, Mitsuhashi N, Nagashima H, Sakurai H, Murata O, Ishizeki K, Shimaya S, Hayakawa K, Niibe H.
    Radiat Med; 1996 Jun; 14(6):343-7. PubMed ID: 9132818
    [Abstract] [Full Text] [Related]

  • 16. The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy.
    Prummel MF, Gerding MN, Zonneveld FW, Wiersinga WM.
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):205-9. PubMed ID: 11207635
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.